Navigation Links
Holiday Gift From Big Pharma

Mondays Wall Street Journal featured the news of pharmaceutical giant Pfizer acquiring Midwest biotech company Esperion Therapeutics for $1.3 billion.

Esperion, which is based in Ann Arbor, Mich., develops cardiovascular medicine that may be useful for the treatment of the heart disease atherosclerosis. Remember that Pfizer has......

Full article >>> om/" target="blank">Genitope (cancer vaccines) are trading below the initial IPO price. As a group, the first seven are down 16 percent since their offerings.

Eyetech Pharmaceuticals was queued up for close to a $150 million IPO. Though Eyetech has a deal with Pfizer valued up to $745 million for its macular degeneration product......

Full article >>>
'"/>

Source:wistechnology.com By Michael Rosen 12/22/03


Related biology technology :

1. Unwrapping Political Perks for the Holidays
2. Holiday Tech Gizmos to Give and Get
3. Analyzing Trace-Level Impurities of a Pharmaceutical Intermediate Using an LCQ Deca Ion Trap Mass Spectrometer and the Mass Frontier Software Package
4. Rapid SNP Genotyping of the Pharmacogenomically Important Allele CYP2D6*4 Using Real-Time qPCR on the DNA Engine Opticon 2 System
5. Practical Applications of HyperDSC in a Pharmaceutical Laboratory
6. World Class Life Science and Pharmaceutical Companies Leverage DoveBid s Global Reach for Asset Management and Disposition
7. Deltanoid Pharmaceuticals begins phase II osteoporosis study
8. The deconstruction of Big Pharma
9. First half of 2006 roundup: Big Pharma trumps biotech
10. Big Pharmas continued hunger and search for new products
11. Leading global Big Pharma companies of 2005
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 system ... experiments and avoiding the use of exogenous expression plasmids. The simplicity of programming ... systematic gain-of-function studies. , This complement to loss-of-function studies, such as with ...
(Date:10/11/2017)... HILLS, Calif. , Oct. 11, 2017  SkylineDx today ... (ICR) and University of Leeds ... risk-stratify patients with multiple myeloma (MM), in a multi-centric Phase ... University of Leeds is the sponsor ... and ICR will perform the testing services to include high-risk ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... conjugate (ADC) therapeutics, today confirmed licensing rights that give it exclusive global ... technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). Additionally, ...
(Date:10/10/2017)... ... 10, 2017 , ... USDM Life Sciences , the ... sciences and healthcare industries, announces a presentation by Subbu Viswanathan and Jennifer Jaye ... GxP Validation for Agile Cloud Platforms,” will present a revolutionary approach to achieving ...
Breaking Biology Technology:
(Date:8/15/2017)... Va. , Aug. 15 2017   ivWatch LLC , ... of intravenous (IV) therapy, today announced receipt of its ISO 13485 ... developed by the International Organization for Standardization (ISO®). ... ivWatch Model 400 Continuous Monitoring device for the ... "This is ...
(Date:5/23/2017)... first robotic gym for the rehabilitation and functional motor sense evaluation of ... Italy . The first 30 robots will be available from June ... . The technology was developed and patented at the IIT laboratories and ... thanks to a 10 million euro investment from entrepreneur Sergio Dompè. ... ...
(Date:4/19/2017)... New York , April 19, 2017 ... competitive, as its vendor landscape is marked by the ... the market is however held by five major players ... Safran. Together these companies accounted for nearly 61% of ... of the leading companies in the global military biometrics ...
Breaking Biology News(10 mins):